261 related articles for article (PubMed ID: 17404104)
1. Chemosensitization of cancer in vitro and in vivo by nitric oxide signaling.
Frederiksen LJ; Sullivan R; Maxwell LR; Macdonald-Goodfellow SK; Adams MA; Bennett BM; Siemens DR; Graham CH
Clin Cancer Res; 2007 Apr; 13(7):2199-206. PubMed ID: 17404104
[TBL] [Abstract][Full Text] [Related]
2. Hypoxia induced resistance to doxorubicin in prostate cancer cells is inhibited by low concentrations of glyceryl trinitrate.
Frederiksen LJ; Siemens DR; Heaton JP; Maxwell LR; Adams MA; Graham CH
J Urol; 2003 Sep; 170(3):1003-7. PubMed ID: 12913759
[TBL] [Abstract][Full Text] [Related]
3. Nitric oxide attenuates resistance to doxorubicin in three-dimensional aggregates of human breast carcinoma cells.
Muir CP; Adams MA; Graham CH
Breast Cancer Res Treat; 2006 Mar; 96(2):169-76. PubMed ID: 16331349
[TBL] [Abstract][Full Text] [Related]
4. Atrial natriuretic peptide attenuates hypoxia induced chemoresistance in prostate cancer cells.
Bell EN; Tse MY; Frederiksen LJ; Gardhouse A; Pang SC; Graham CH; Siemens DR
J Urol; 2007 Feb; 177(2):751-6. PubMed ID: 17222675
[TBL] [Abstract][Full Text] [Related]
5. Fluoxetine inhibits multidrug resistance extrusion pumps and enhances responses to chemotherapy in syngeneic and in human xenograft mouse tumor models.
Peer D; Dekel Y; Melikhov D; Margalit R
Cancer Res; 2004 Oct; 64(20):7562-9. PubMed ID: 15492283
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of hypoxia-inducible factor 1α accumulation by glyceryl trinitrate and cyclic guanosine monophosphate.
Kim J; Barsoum IB; Loh H; Paré JF; Siemens DR; Graham CH
Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31912870
[TBL] [Abstract][Full Text] [Related]
7. Cytokines, nitric oxide, and cGMP modulate the permeability of an in vitro model of the human blood-brain barrier.
Wong D; Dorovini-Zis K; Vincent SR
Exp Neurol; 2004 Dec; 190(2):446-55. PubMed ID: 15530883
[TBL] [Abstract][Full Text] [Related]
8. Nitric oxide and cGMP signal transduction positively regulates the motility of human neuronal precursor (NT2) cells.
Tegenge MA; Bicker G
J Neurochem; 2009 Sep; 110(6):1828-41. PubMed ID: 19627439
[TBL] [Abstract][Full Text] [Related]
9. Elucidation of the therapeutic enhancer mechanism of poly-S-nitrosated human serum albumin against multidrug-resistant tumor in animal models.
Ishima Y; Hara M; Kragh-Hansen U; Inoue A; Suenaga A; Kai T; Watanabe H; Otagiri M; Maruyama T
J Control Release; 2012 Nov; 164(1):1-7. PubMed ID: 23063551
[TBL] [Abstract][Full Text] [Related]
10. Ghrelin induces growth hormone secretion via a nitric oxide/cGMP signalling pathway.
Rodríguez-Pacheco F; Luque RM; Tena-Sempere M; Malagón MM; Castaño JP
J Neuroendocrinol; 2008 Mar; 20(3):406-12. PubMed ID: 18208548
[TBL] [Abstract][Full Text] [Related]
11. Phase II study of nitric oxide donor for men with increasing prostate-specific antigen level after surgery or radiotherapy for prostate cancer.
Siemens DR; Heaton JP; Adams MA; Kawakami J; Graham CH
Urology; 2009 Oct; 74(4):878-83. PubMed ID: 19476985
[TBL] [Abstract][Full Text] [Related]
12. A common pathway for nitric oxide release from NO-aspirin and glyceryl trinitrate.
Grosser N; Schröder H
Biochem Biophys Res Commun; 2000 Jul; 274(1):255-8. PubMed ID: 10903927
[TBL] [Abstract][Full Text] [Related]
13. Stimulation of the nitric oxide/cyclic guanosine monophosphate signaling pathway elicits human sperm chemotaxis in vitro.
Miraglia E; Rullo ML; Bosia A; Massobrio M; Revelli A; Ghigo D
Fertil Steril; 2007 May; 87(5):1059-63. PubMed ID: 17280661
[TBL] [Abstract][Full Text] [Related]
14. REIC/Dkk-3 overexpression downregulates P-glycoprotein in multidrug-resistant MCF7/ADR cells and induces apoptosis in breast cancer.
Kawasaki K; Watanabe M; Sakaguchi M; Ogasawara Y; Ochiai K; Nasu Y; Doihara H; Kashiwakura Y; Huh NH; Kumon H; Date H
Cancer Gene Ther; 2009 Jan; 16(1):65-72. PubMed ID: 18654608
[TBL] [Abstract][Full Text] [Related]
15. Preclinical antitumor activity of the oral platinum analog satraplatin.
Wosikowski K; Lamphere L; Unteregger G; Jung V; Kaplan F; Xu JP; Rattel B; Caligiuri M
Cancer Chemother Pharmacol; 2007 Sep; 60(4):589-600. PubMed ID: 17541592
[TBL] [Abstract][Full Text] [Related]
16. Modulation of the cGMP signaling pathway by melatonin in pancreatic beta-cells.
Stumpf I; Bazwinsky I; Peschke E
J Pineal Res; 2009 Mar; 46(2):140-7. PubMed ID: 19175857
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of Src tyrosine kinase reverts chemoresistance toward 5-fluorouracil in human pancreatic carcinoma cells: an involvement of epidermal growth factor receptor signaling.
Ischenko I; Camaj P; Seeliger H; Kleespies A; Guba M; De Toni EN; Schwarz B; Graeb C; Eichhorn ME; Jauch KW; Bruns CJ
Oncogene; 2008 Dec; 27(57):7212-22. PubMed ID: 18794807
[TBL] [Abstract][Full Text] [Related]
18. Hypoxia increases tumor cell shedding of MHC class I chain-related molecule: role of nitric oxide.
Siemens DR; Hu N; Sheikhi AK; Chung E; Frederiksen LJ; Pross H; Graham CH
Cancer Res; 2008 Jun; 68(12):4746-53. PubMed ID: 18559521
[TBL] [Abstract][Full Text] [Related]
19. Effects of manipulating the nitric oxide/cyclic GMP pathway on bovine oocyte meiotic resumption in vitro.
Bilodeau-Goeseels S
Theriogenology; 2007 Sep; 68(5):693-701. PubMed ID: 17604095
[TBL] [Abstract][Full Text] [Related]
20. Nitric oxide-mediated regulation of chemosensitivity in cancer cells.
Matthews NE; Adams MA; Maxwell LR; Gofton TE; Graham CH
J Natl Cancer Inst; 2001 Dec; 93(24):1879-85. PubMed ID: 11752013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
